MINNEAPOLIS, March 5, 2026 /PRNewswire/ — Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) ...
As expiration dates for key patents approach, the blockbuster cancer drug pembrolizumab (Keytruda) reigned as the biggest pharma moneymaker one more time, edging out the diabetes/weight-loss drug ...
Imagine treating a tumor without a scalpel or incision – no bleeding, no post-surgical complications, no prolonged hospital stays! That is no longer science fiction. In recent years, medical ...
The milestone procedure saw Professor Prokar Dasgupta, based at The London Clinic's robotic center in Harley Street, operate ...
A surgeon in London has successfully removed a patient’s prostate in Gibraltar using a ...
A pioneering remote robotic surgery, the first of its kind in the UK, has been hailed as a significant medical "milestone" ...
A prostate cancer patient in Gibraltar has been operated on remotely by a surgeon in London. On Wednesday, Prof Prokar ...
Profound Medical (NASDAQ:PROF) reported fourth-quarter 2025 revenue of $6.0 million, including $2.3 million in recurring ...
The pioneering procedure went 'extremely well', with patient Paul Buxton reporting feeling 'fantastic' just four days after the surgery which he did from 2,400 km away ...
In oligometastatic castration-resistant prostate cancer, the rationale to use local SBRT is improved disease control.